Cash Flow Extrawell Pharmaceutical Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-982.00
227.00
-157.00
134.00
135.00
-116.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
-4.00
-7.00
3.00
2.00
1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3.00
0.00
0.00
3.00
-1.00
0.00
Cash Flow from Investing Activities
-5.00
-13.00
-6.00
-12.00
-9.00
0.00
Cash Flow from Financing Activities
13.00
-1.00
-1.00
-2.00
-1.00
-1.00
Net Cash Inflow / Outflow
12.00
-16.00
-8.00
-11.00
-14.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
0.00
-1.00
3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Extrawell Pharmaceutical Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-982.8
-28.5923741457313
-954.00
-3337.28%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.424
-37.3867741589211
37.00
101.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3.039
-58.8516607122633
61.00
105.16%
Cash Flow from Investing Activities
-5.818
11.2844656723689
-16.00
-151.56%
Cash Flow from Financing Activities
13.366
2.21134315290343
11.00
504.43%
Net Cash Inflow / Outflow
12.528
-45.3656125973274
57.00
127.62%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.941
-0.0097607103365036
1.00
19985.85%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 610.76% vs 23.62% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
3.04
-0.59
610.76%
Footer loading
